Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículo Destacado en trastornos del movimiento

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2053 ARTíCULOS , VIENDO DEL 46 AL 60

PUBMED

Gastrointestinal Involvement in Extra-Digestive Disease: Which Is the Role of Fecal Calprotectin?

Saviano A, Candelli M, Zanza C, Piccioni A, Migneco A, Ojetti V.

Medicina (Kaunas). 2022 Oct 2;58(10):1384. doi: 10.3390/medicina58101384.

0

0

0

PUBMED

Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives

Hernaiz A, Toivonen JM, Bolea R, Martín-Burriel I.

Int J Mol Sci. 2022 Oct 20;23(20):12609. doi: 10.3390/ijms232012609.

0

0

0

PUBMED

Putaminal Recombinant Glucocerebrosidase Delivery with Magnetic Resonance-Guided Focused Ultrasound in Parkinson's Disease: A Phase I Study

Meng Y, Pople CB, Huang Y, Jones RM, Ottoy J, Goubran M, Oliveira LM, Davidson B, Lawrence LSP, Lau AZ, Bethune A, Maralani P, Abrahao A, Hamani C, Hynynen K, Kalia SK, Lipsman N, Kalia LV.

Mov Disord. 2022 Oct;37(10):2134-2139. doi: 10.1002/mds.29190. Epub 2022 Sep 11.

0

0

0

PUBMED

A systematic review of brain morphometry related to deep brain stimulation outcome in Parkinson's disease

Wang F, Lai Y, Pan Y, Li H, Liu Q, Sun B.

NPJ Parkinsons Dis. 2022 Oct 13;8(1):130. doi: 10.1038/s41531-022-00403-x.

0

0

0

PUBMED

Alzheimer's Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms

Abduljawad AA, Elawad MA, Elkhalifa MEM, Ahmed A, Hamdoon AAE, Salim LHM, Ashraf M, Ayaz M, Hassan SSU, Bungau S.

Molecules. 2022 Oct 11;27(20):6804. doi: 10.3390/molecules27206804.

0

0

0

PUBMED

Clinical application of prion-like seeding in α-synucleinopathies: Early and non-invasive diagnosis and therapeutic development

Li J, Luo H, Zheng H, Duan S, Zhao T, Yuan Y, Liu Y, Zhang X, Wang Y, Yang J, Xu Y.

Front Mol Neurosci. 2022 Oct 10;15:975619. doi: 10.3389/fnmol.2022.975619. eCollection 2022.

0

0

0

PUBMED

Efficacy of repetitive transcranial magnetic stimulation in Parkinson's disease: A systematic review and meta-analysis of randomised controlled trials

Zhang W, Deng B, Xie F, Zhou H, Guo JF, Jiang H, Sim A, Tang B, Wang Q.

EClinicalMedicine. 2022 Jul 29;52:101589. doi: 10.1016/j.eclinm.2022.101589. eCollection 2022 Oct.

0

0

0

PUBMED

The effects of physiotherapy treatments on dysphagia in Parkinson's disease: A systematic review of randomized controlled trials

Wen X, Liu Z, Liu X, Peng Y, Liu H.

Brain Res Bull. 2022 Oct 1;188:59-66. doi: 10.1016/j.brainresbull.2022.07.016. Epub 2022 Jul 23.

0

0

0

PUBMED

The advantage of the mini-electrode-equipped catheter for the radiofrequency ablation of paroxysmal supraventricular tachycardia

Choi Y, Kim SH, Kim H, Park JW, Ha YW, Hwang Y, Kim JH, Jang SW, Oh YS.

J Cardiovasc Electrophysiol. 2022 Oct;33(10):2164-2171. doi: 10.1111/jce.15639. Epub 2022 Aug 24.

0

0

0

PUBMED

Do we start too late? Insights from the real-world non-interventional BALANCE study on the present use of levodopa/carbidopa intestinal gel in advanced Parkinson's disease in Germany and Switzerland

Weiss D, Ebersbach G, Möller JC, Schwarz J, Arlt C, Fritz B, Sensken SC, Eggert K.

Parkinsonism Relat Disord. 2022 Oct;103:85-91. doi: 10.1016/j.parkreldis.2022.08.018. Epub 2022 Aug 24.

0

0

0

PUBMED

Mitochondrial proteotoxicity: implications and ubiquitin-dependent quality control mechanisms

Karbowski M, Oshima Y, Verhoeven N.

Cell Mol Life Sci. 2022 Oct 29;79(11):574. doi: 10.1007/s00018-022-04604-8.

0

0

0

PUBMED

Therapeutic efficacy and cognitive adverse events of overactive bladder medication in patients with central nervous system Disorders-A cohort study

Chen SF, Chuang YC, Wang CC, Liao CH, Kuo HC.

J Formos Med Assoc. 2022 Oct;121(10):2101-2108. doi: 10.1016/j.jfma.2022.04.004. Epub 2022 Apr 18.

0

0

0

PUBMED

Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson's disease: A systematic review

Liu SF, Li LY, Zhuang JL, Li MM, Ye LC, Chen XR, Lin S, Chen CN.

Front Neurol. 2022 Oct 3;13:950715. doi: 10.3389/fneur.2022.950715. eCollection 2022.

0

0

0

PUBMED

The mini electrode-equipped catheter: Utility for paroxysmal supraventricular tachycardia ablation

Iwasawa J, Koruth JS.

J Cardiovasc Electrophysiol. 2022 Oct;33(10):2172-2173. doi: 10.1111/jce.15640. Epub 2022 Aug 24.

0

0

0

PUBMED

Sex Differences in Dopaminergic Vulnerability to Environmental Toxicants - Implications for Parkinson's Disease

Adamson A, Buck SA, Freyberg Z, De Miranda BR.

Curr Environ Health Rep. 2022 Oct 6. doi: 10.1007/s40572-022-00380-6. Online ahead of print.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy